Company intelligence / Profile preview

ViQi

Santa Barbara, California, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

ViQi customizes image-based assays and AI-driven analytics to accelerate drug discovery, especially in 3D cultures, virology (including rapid viral infectivity analysis), and high-content screening. Their platform has enabled rapid, automated assays for viral infectivity that can deliver results within hours, and their cloud-based analysis tools are used by pharma, biotech, and academic clients in drug screening and preclinical research[1][3].

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceSoftware
Industry: Drug Discovery Services

Partnerships

Araceli Biosciences (Araceli Endeavor® platform integration)[1]

Beyond the preview

Go deeper on ViQi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViQi.

Explore the full profile